After-Hours Movers 10/29: First Solar (FSLR) Up on Results/Guidance; Elan (ELN) & Biogen (BIIB) Sinks on TYSABRI PML News
More News related to AKNS
- Akeena Solar (AKNS) Converts Silver Mountain Vineyards to 100% Solar Energy
- Akeena Solar Converts Silver Mountain Vineyards to 100 Percent Solar Energy
- Akeena Solar, MCC Construction Complete 660-kilowatt Solar Installation on California Air National Guard Base in Fresno
- Akeena Solar Named SEIA Industry Innovator
- Charles H. Johnson & Associates Announces Filing of Securities Class Action Against Akeena Solar, Inc.
More News related to BBBB
- Growing Demand for Online Learning Not Yet Matched by Opportunities at K-12 Schools, Districts
- E-Learning Community to Come Together at BbWorld
- Blackboard Connect Supports Growth of New York City's Successful Notification Program
- Blackboard Inc. to Present at the Cowen and Company 20/20 TMT Conference
- Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform
More News related to BIIB
- Biogen Idec to Report Second Quarter 2009 Financial Results on July 16, 2009
- Biogen Idec (BIIB) volatility low into JNJ $1B investment in Elan
- Leerink Swann Upgrades Acorda Therapeutics (ACOR) Two-Notches to Outperform
- Acorda (ACOR) CEO On CNBC
- Acorda (ACOR) Enters License Agreement With Biogen Idec (BIIB) For Fampridine-SR Outside the U.S.
StreetInsider.com After-Hours Movers
Elan Corp. plc (NYSE: ELN) 28% LOWER; On October 29, 2008, relevant regulatory agencies were notified of a confirmed case of progressive multifocal leukoencephalopathy (PML) in a multiple sclerosis (MS) patient treated with TYSABRI in the commercial setting in the United States. Additional information about this case is set forth below.
First Solar, Inc. (Nasdaq: FSLR) 16% HIGHER; reports Q3 EPS of $1.20, versus the analyst estimate of $1.01. Revenue for the quarter was $348.7 million, versus the consensus of $339.29 million. Sees FY08 sales of $1.22-$1.24 billion, versus the Street estimate of $1.21 billion. Sees FY09 sales of $2-$2.1 billion, versus the consensus of $2.13 billion.
Biogen Idec Inc. (Nasdaq: BIIB) 12% LOWER; On October 29, 2008, relevant regulatory agencies were notified of a confirmed case of progressive multifocal leukoencephalopathy (PML) in a multiple sclerosis (MS) patient treated with TYSABRI in the commercial setting in the United States. Additional information about this case is set forth below.
Evergreen Solar Inc. (Nasdaq: ESLR) 11% HIGHER; First Solar earnings
Trina Solar Ltd. (NYSE: TSL) 10% HIGHER; First Solar earnings
International Coal Group, Inc (NYSE: ICO) 10% LOWER; reports Q3 EPS of $0.06, 4 cents better than the analyst estimate of $0.02. Revenue for the quarter was $309.2 million, versus the consensus of $294.22 million.
Suntech Power Holdings Co. Ltd. (NYSE: STP) 9% HIGHER; First Solar earnings
SunPower Corporation (SPWRA) 8% HIGHER; First Solar earnings
ReneSola Ltd. (NYSE: SOL) 7% HIGHER; First Solar earnings
Akeena Solar, Inc. (Nasdaq: AKNS) 7% HIGHER; First Solar earnings
Solarfun Power Holdings Co. Ltd. (Nasdaq: SOLF) 7% HIGHER; First Solar earnings
Symantec (Nasdaq: SYMC) 7% LOWER; reports Q3 EPS of $0.37, 2 cents better than the analyst estimate of $0.35. Revenue for the quarter was $1.52 billion, versus the consensus of $1.54 billion. Sees Q3 revenues $1.45B to 1.55B versus 1.61 billion. Sees Q3 EPS 30-33 cents versus 36 cents.
Cognex (Nasdaq: CGNX) 7% LOWER; reports Q3 EPS of $0.18, 2 cents better than the analyst estimate of $0.16. Revenue for the quarter was $63.3 million, versus the consensus of $63.55 million. Cognex sees Q4 EPS 3c to 10c versus 18c. Sees Q4 revenues $53-$58M versus $64.5M.
Symantec (Nasdaq: SYMC) 7% LOWER; reports Q3 EPS of $0.37, 2 cents better than the analyst estimate of $0.35. Revenue for the quarter was $1.52 billion, versus the consensus of $1.54 billion. Sees Q3 revenues $1.45B to 1.55B versus 1.61 billion. Sees Q3 EPS 30-33 cents versus 36 cents.
Sauer-Danfoss (NYSE: SHS) 6% LOWER; reports Q3 EPS of $0.22, 3 cents below the analyst estimate of $0.25. Revenue for the quarter was $490.2 million, versus the consensus of $456.30 million. Sauer-Danfoss sees FY08 EPS $1.15 to $1.25 versus $1.46 consensus.
Maxim Integrated Products (Nasdaq: MXIM) 6% HIGHER; reports Q1 EPS of $0.21, 1 cent below the analyst estimate of $0.22. Revenue for the quarter was $501.2 million, versus the consensus of $501.79 million. Sees Q2 revenue $410M to $440M versus $497.3 million.
JDSU (Nasdaq: JDSU) 5% LOWER; reports Q1 EPS of $0.11, 2 cents better than the analyst estimate of $0.09. Revenue for the quarter was $387 million, versus the consensus of $386.06 million. Sees Q2 revs of $360-$390 million, versus the consensus of $417 million.
Blackboard, Inc. (Nasdaq: BBBB) 4% LOWER; reports Q3 EPS of $0.25, 5 cents better than the analyst estimate of $0.20. Revenue for the quarter was $83.1 million, versus the consensus of $83.06 million. Sees Q4 EPS of $0.22-$0.25, versus the consensus of $0.28 and revs of $82.9-$84.9 million, versus the consensus of $86.7 million.
Tesoro Corporation (NYSE: TSO) 2% HIGHER; reports Q3 EPS of $1.86, 38 cents better than the analyst estimate of $1.48. Revenue for the quarter was $8.7 billion, versus the consensus of $7.81 billion.
Get This Report Daily Here:http://www.streetinsider.com/entities/After-Hours+Movers
Related Categories
Special ReportsStocks Mentioned
-0.02
+21.68Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
